Species-related pharmacological heterogeneity of histamine H3 receptors

被引:48
作者
Ireland-Denny, L [1 ]
Parihar, AS [1 ]
Miller, TR [1 ]
Kang, CH [1 ]
Krueger, KM [1 ]
Esbenshade, TA [1 ]
Hancock, AA [1 ]
机构
[1] Abbott Labs, Dept R4MN, Abbott Pk, IL 60064 USA
关键词
histamine H-3 receptor; receptor heterogeneity; radioligand binding; ileum; guinea pig; electrical field stimulation;
D O I
10.1016/S0014-2999(01)01518-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We compared radioligand binding and functional data for histamine H-3 receptor ligands across different tissues or species to evaluate the basis for pharmacological evidence of receptor heterogeneity previously reported. Agonist binding affinities showed correlation coefficients near unity in comparing human, dog, rat, and guinea pig cerebral cortical histamine H-3 receptors. Antagonist binding affinities revealed lower correlations fur human compared to dog, rat, or guinea pig, suggesting species-based pharmacological differences. The functional potencies of histamine H-3 receptor antagonists in field-stimulated guinea pig ileum were highly correlated to binding affinities for guinea pig, dog, and, to a lesser extent, rat cerebral cortex. However, antagonist binding affinity at human cerebral cortex did not correlate well with guinea pig ileum functional potency, These results suggest significant interspecies histamine H-3 receptor heterogeneity, consistent with recent receptor gene sequence data. Therefore, genetic heterogeneity, rather than peripheral and central histamine H-3 receptor diversity, is responsible for the pharmacological differences observed. (C), 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 44 条
[31]   NOVEL HISTAMINE-H-3 RECEPTOR ANTAGONISTS - AFFINITIES IN AN H-3 RECEPTOR-BINDING ASSAY AND POTENCIES IN 2 FUNCTIONAL H-3 RECEPTOR MODELS [J].
SCHLICKER, E ;
KATHMANN, M ;
REIDEMEISTER, S ;
STARK, H ;
SCHUNACK, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (04) :1043-1048
[32]  
Schlicker E, 1996, N-S ARCH PHARMACOL, V353, P482
[33]  
SCHLICKER E, 1988, N-S ARCH PHARMACOL, V337, P558
[34]   Cloning and cerebral expression of the guinea pig histamine H3 receptor:: evidence for two isoforms [J].
Tardivel-Lacombe, J ;
Rouleau, A ;
Héron, A ;
Morisset, S ;
Pillot, C ;
Cochois, V ;
Schwartz, JC ;
Arrang, JM .
NEUROREPORT, 2000, 11 (04) :755-759
[35]   CHARACTERIZATION OF HISTAMINE-H-3 RECEPTORS CONTROLLING NONADRENERGIC NONCHOLINERGIC CONTRACTIONS OF THE GUINEA-PIG ISOLATED ILEUM [J].
TAYLOR, SJ ;
KILPATRICK, GJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (03) :667-674
[36]   High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models [J].
Tedford, CE ;
Hoffmann, M ;
Seyedi, N ;
Maruyama, R ;
Levi, R ;
Yates, SL ;
Ali, SM ;
Phillips, JG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 351 (03) :307-311
[37]   Evaluation of agonist efficacy and receptor reserve for alpha(2D)-adrenergic receptor regulated g protein activation in PC12 cell membranes [J].
Tian, WN ;
Duzic, E ;
Deth, RC .
PHARMACOLOGY, 1996, 52 (04) :252-262
[38]   HISTAMINE H-3 LIGANDS - JUST PHARMACOLOGICAL TOOLS OR POTENTIAL THERAPEUTIC AGENTS [J].
TIMMERMAN, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (01) :4-11
[39]  
TRZECIAKOWSKI JP, 1987, J PHARMACOL EXP THER, V243, P874
[40]   The profiles of human and primate [3H]Nα-methylhistamine binding differ from that of rodents [J].
West, RE ;
Wu, RL ;
Billah, MM ;
Egan, RW ;
Anthes, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 377 (2-3) :233-239